Malignant Bile Duct Neoplasm — Trials

Malignant Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

881 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 221
Recruiting: 125
Ph III recruiting: 7
Growth YoY: +10.4%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (119)

clinicaltrialsPublishedShowing 1–50 of 167 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04645160	Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers	recruiting	Phase 1 / Phase 2	31	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT07673341	[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma	recruiting	Phase 2	22	University of WashingtonOTHER	1	Sep 25, 2026